Assessment of Drug-eluting Ureteral Stent on Bacterial Adherence and Biofilm Formation

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Renal CalculiUreteral Obstruction
Interventions
DEVICE

Ureteral Stent

triclosan-eluting ureteral stent

DEVICE

Ureteral Stent

Percuflex Plus Stent as the control

Trial Locations (1)

N6A 4V2

Urology, St. Joseph's Hospital, London

Sponsors
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER